Study of Aripiprazole in Patients With a History of Bipolar Disorder
Phase 3
Completed
- Conditions
- Bipolar Disorder
- Registration Number
- NCT00036348
- Brief Summary
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of aripiprazole in treating bipolar disorder as studied in NCT00036348?
How does aripiprazole compare to other antipsychotics like olanzapine in managing bipolar disorder symptoms?
What biomarkers are associated with response to aripiprazole in bipolar disorder patients from NCT00036348?
What adverse events were reported in NCT00036348 and how were they managed in clinical practice?
How does aripiprazole's mechanism of dopamine receptor partial agonism impact long-term outcomes in bipolar disorder?
Trial Locations
- Locations (1)
Local Institution
🇺🇸San Antonio, Texas, United States
Local Institution🇺🇸San Antonio, Texas, United States